GlaxoSmithKline plc (ADR) (NYSE:GSK)
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
rurbey
(< 20)
Submitted: 2/6/2012 8:46:11 PM :
Start Price:
$44.29
GSK Score:
+0.90
World is getting older
Recs
NajdorfSicilian
(99.71)
Submitted: 11/29/2011 2:34:51 PM :
Start Price:
$42.80
GSK Score:
-7.25
simply too cheap
Recs
BinyaminK
(21.70)
Submitted: 11/9/2011 1:47:16 PM :
Start Price:
$43.50
GSK Score:
-5.38
This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.
Recs
WilliamCrook2003
(74.54)
Submitted: 10/21/2011 12:38:54 PM :
Start Price:
$44.22
GSK Score:
-7.72
Potential to make somebody some money.
Recs
MFBriguy
(99.84)
Submitted: 9/8/2011 12:20:56 PM :
Start Price:
$41.59
GSK Score:
-4.35
GG Best Buy Now
Recs
TMFBuck
(75.94)
Submitted: 8/18/2011 3:20:29 PM :
Start Price:
$40.66
GSK Score:
-8.01
Access to and strength in emerging markets. A strong dividend is currently underappreciated.
Recs
headyinvestor
(47.72)
Submitted: 8/15/2011 9:44:05 AM :
Start Price:
$41.48
GSK Score:
-4.39
People need drugs, regardless of the economy. They have the added bonus of an established consumer goods line. Pharma was oversold and this stock will recover.
Recs
joecourt
(< 20)
Submitted: 8/12/2011 1:01:35 PM :
Start Price:
$40.90
GSK Score:
-3.79
some of the best consumer meds and a good dividend
Recs
RedandBlack
(97.37)
Submitted: 6/9/2011 9:17:05 PM :
Start Price:
$40.92
GSK Score:
+5.08
They are partnering with other drug makers in emerging markets (Dr. Reddy's in India) and investing in consumer products (Tums, Sominex). Nice dividend. Management during the last update indicated they would be buying back stock in on the high end of the $1-$2 billion range. Outperform.
Recs
RetiredAt37
(62.05)
Submitted: 5/4/2011 9:03:19 AM :
Start Price:
$42.58
GSK Score:
+6.06
Basic value play
Recs
FuriousGreen
(56.25)
Submitted: 5/2/2011 2:15:14 PM :
Start Price:
$42.24
GSK Score:
+7.59
Aging boomers will swarm on this stock and make sweet, sweet love to it.
Recs
Recs
cllqmb
(< 20)
Submitted: 3/12/2011 10:38:11 PM :
Start Price:
$37.23
GSK Score:
+16.83
FDA approval of BENLYSTA will bring profits from US markets and European approval is on the way later this year. Revenues are going to increase immensely over the next few years and unless there is a drug approval that will compete with the current monopolistic standing of this new drug, both Human Genome and Glaxosmithkline will do extremely well.
Recs
andycheung2000
(< 20)
Submitted: 2/23/2011 7:14:28 PM :
Start Price:
$36.75
GSK Score:
+19.11
Excellent management. Solid balance sheet. Strong consumer healthcare, especially in emerging markets. Very strong vaccines division. Doesn't have too many patents expiry issues. Best drugs pipeline of the major pharmaceuticals. Great dividend.
Recs
billybob4148
(53.01)
Submitted: 2/17/2011 10:11:14 AM :
Start Price:
$36.98
GSK Score:
+20.40
Great company, dividend among highest in sector, awesome forward P/E ratio of 10, lots of room to grow, Buffett is buying, what is not to like!!
Recs
cabincruser
(81.32)
Submitted: 2/15/2011 1:39:53 PM :
Start Price:
$36.90
GSK Score:
+20.31
dividend portfolio, good average 5 year dividend growth
Recs
plumbob13
(< 20)
Submitted: 1/12/2011 4:09:38 PM :
Start Price:
$37.09
GSK Score:
+16.18
under-priced, dividend is nice
Recs
amckane
(78.91)
Submitted: 1/2/2011 10:54:23 PM :
Start Price:
$37.10
GSK Score:
+13.66
It's a "dividend stock", the next "investing" fad!
Recs
noguarantees
(61.95)
Submitted: 12/8/2010 3:14:18 AM :
Start Price:
$37.34
GSK Score:
+10.59
GSK is a good investment because it does not depend on reviews of brokers and experts such as Zacks. Take for example NKBP: Zacks gives it as "strong buy" for the past nine months, in fact NKBP continues to fall
Recs
smartorbandit
(62.53)
Submitted: 11/23/2010 8:10:00 AM :
Start Price:
$37.21
GSK Score:
+7.14
good GSK but news and estimates lying on NKBP (nasdaq)
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 219 : 1 2 3 4 5 6 7 8 9 10 Next »